Raymond James Maintains Strong Buy on Aveanna Healthcare Hldgs, Lowers Price Target to $12
Raymond James analyst John Ransom maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Strong Buy and lowers the price target from $15 to $12.
Uncategorized
From BZ Small Cap Event: Virios Therapeutics CEO Greg Duncan Now Speaking Live
https://www.youtube.com/watch?v=Jrcq_ymSBt0
Related Posts
Marriott Shares Gain On Q1 Earnings Beat, Resumed Dividend
Marriott International Inc (NASDAQ:MAR) reported first-quarter FY22 sales growth of 81.3% year-on-year, to $4.2 billion, beating the consensus of $4.11 billion.…
Notable Alphabet Insider Trades $6.7M In Company Stock
J. Kent Walker, SVP And Global Affairs Clo at Alphabet (NASDAQ:GOOG), made a large buy and sell of company shares on September 30, according to a new SEC filing.
Quaker Houghton Enters Joint Venture With Grindaix
Quaker Houghton (NYSE:KWR), the leader in industrial process fluids has entered into an exclusive joint venture with Grindaix GmbH, a German-based, high-tech provider of coolant control and delivery